Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Liabilities and Shareholders Equity (2020 - 2025)

Treace Medical Concepts' Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $190.6 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 12.21% year-over-year to $190.6 million; the TTM value through Dec 2025 reached $799.5 million, down 11.06%, while the annual FY2025 figure was $190.6 million, 12.21% down from the prior year.
  • Liabilities and Shareholders Equity reached $190.6 million in Q4 2025 per TMCI's latest filing, down from $196.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $251.9 million in Q4 2023 to a low of $37.4 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $188.4 million, with a median of $201.2 million recorded in 2025.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 291.93% in 2022, then dropped 15.19% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $140.8 million in 2021, then rose by 12.93% to $159.0 million in 2022, then surged by 58.41% to $251.9 million in 2023, then decreased by 13.82% to $217.1 million in 2024, then fell by 12.21% to $190.6 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Liabilities and Shareholders Equity are $190.6 million (Q4 2025), $196.6 million (Q3 2025), and $206.4 million (Q2 2025).